Riskpilot← Back to searchSign inGet full accessWensmark Fysioterapi i Helsingborg AB
ABActiveOrg 5591876007Skimmelvägen 22Physiotherapy activities · NACE 8695Est. 20181 employees
Revenue 2025
SEK 1,3M
+63% vs 2024
EBITDA margin
10.5%
-30% vs 2024
Equity ratio
12.0%
Financial strength
Net profit 2025
SEK 26K
-83% vs 2024
| Revenue | SEK 1,3M | +63% |
| EBITDA | SEK 134K | -30% |
| Net profit | SEK 26K | -83% |
| Total assets | SEK 722K | -5% |
| Equity | SEK 87K | -59% |
| Employees | 1 | — |
Legal name
Wensmark Fysioterapi i Helsingborg AB
Org number
5591876007
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
19 december 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukgymnastik, utbildning och konsultationer inom fysioterapi och hälsa, bolaget skall även bedriva handel med värdepapper samt idka därmed förenlig verksamhet.
Address
Skimmelvägen 22
Email
wensmark@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 939 | 783 | 1 278 |
| Staff expenses | — | — | −493 | −389 | −773 |
| EBITDA | −1 | −14 | 177 | 191 | 134 |
| Depreciation & amort. | −0 | — | — | — | −97 |
| EBIT | −1 | −14 | 177 | 191 | 37 |
| Net financials | −1 | — | −0 | −0 | −2 |
| Profit before tax | −1 | −14 | 177 | 191 | 35 |
| Tax | −0 | — | −37 | −40 | −9 |
| Net profit | −1 | −14 | 141 | 151 | 26 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 187 | 170 | 776 | 757 | 722 |
| Equity | 63 | 49 | 190 | 210 | 87 |
| Long-term debt | 121 | 121 | 508 | 430 | 524 |
| Short-term debt | 2 | 0 | 79 | 116 | 111 |
| Total debt | 123 | 121 | 586 | 546 | 635 |
EBITDA margin
10.5%
This company
15.8%
Market median
-34% vs market
20212025
Equity ratio
12.0%
This company
38.2%
Market median
-69% vs market
20212025
Return on equity
30.4%
This company
18.4%
Market median
+65% vs market
20212025
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
20212025
Asset turnover
1.77×
This company
1.12×
Market median
+58% vs market
20212025
Debt / equity
7.34×
This company
0.62×
Market median
-1084% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wensmark Fysioterapi i Helsingborg AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niklas Erik Oliver Wensmark | Board of Directors | 0 companies |
| Ulf Ingemar Svensson | Deputy Board Member | 0 companies |